Skip to main content
Earnings Labs
Standard BioTools Inc. logo

Standard BioTools Inc. (LAB)

NASDAQ·Healthcare·Medical - Devices

$0.84

+1.38%

Mkt Cap $346.53M

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$3.25

Range $3.25$3.25

Implied Upside

+285.4%

Consensus $3.25 vs current $0.84